FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

ACON ONE STEP DRUG SCREEN TEST CARD

K Number: K020771 · Decision May 15, 2002
Classifications
1
FEI Numbers
97
Registration Numbers
97
Same Product Code
144
Applicant Total
85
Review Days
68

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ACON ONE STEP DRUG SCREEN TEST CARD
K Number
K020771
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3250
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
ACON Laboratories, Inc.
Date Received
March 8, 2002
Decision Date
May 15, 2002
Product Code
DIO
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DIO), ordered by most recent decision date.

View all

Other Clearances by ACON Laboratories, Inc.

K Number Device Name
K251697 Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test Strip
K251749 Flowflex Plus RSV + Flu A/B + COVID Home Test
K250085 On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring System
K250377 Flowflex Plus COVID-19 + Flu A/B Home Test
K232715 Distinct® Digital Pregnancy Test
K233373 Flowflex® Plus COVID-19 Home Test
K230828 Flowflex COVID-19 Antigen Home Test
K193318 Distinct® Early Detection Pregnancy Test
K192175 On Call Express II Blood Glucose Monitoring System
K191038 On Call Express Voice Blood Glucose Monitoring System
Search all 85 clearances from ACON Laboratories, Inc. →